A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy
about
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression PathwaysmicroRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.Global Conservation of Protein Status between Cell Lines and XenograftsCancer subclonal genetic architecture as a key to personalized medicine.Mutant p53 in cancer: new functions and therapeutic opportunities.p53 regulates cytoskeleton remodeling to suppress tumor progression.Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.A high definition look at the NF-Y regulome reveals genome-wide associations with selected transcription factors.Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process.p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53.Mutant p53 partners in crime.Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.The p53 Pathway in Glioblastoma
P2860
Q26767396-1D9B7E5F-6F65-4365-8203-1D70734CA515Q30407637-7DB25043-3B99-40CF-92CC-F09B2B604621Q37221907-2EE13BBE-6CBB-418B-9F3B-E0697202B251Q37448116-C20708FF-FEC9-48C5-B321-DC094207B5F1Q38197826-047C696D-BE69-4C7B-B06E-D0FF8934ECBCQ38553239-63DF04CD-28EA-4EF1-857B-5731A4795A29Q38778367-676D1A3E-4229-410D-9D02-ECCF6002A87FQ38792432-2364BC76-A0E7-4B14-A4B0-D7E0CE5231C2Q38846785-C85C69E9-95CE-415E-B198-054F424765EAQ38899532-EF8B992C-BAE6-44E7-84D3-CC24D847F00FQ41841346-C53C03DA-73E0-471D-97F8-DFDDBC2D8290Q47107350-D5D801F3-7967-4A28-9C43-3151651A2FEDQ48690318-FECAA35C-F908-4116-89D2-FC0FC4B2F78DQ51213072-C6C6D580-A0B9-482A-9C4C-9B5AA121E271Q57162865-9C33868A-BEED-44E6-92D8-B40F33FFC6D1
P2860
A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@ast
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@en
type
label
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@ast
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@en
prefLabel
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@ast
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@en
P2093
P2860
P356
P1433
P1476
A novel PTEN/mutant p53/c-Myc/ ...... r cancer prognosis and therapy
@en
P2093
David Schiff
Fadila Guessous
Jungeun Kim
Napoleon Butler
Roger Abounader
Xiaoping Huang
Yaqiong Tang
Ying Zhang
P2860
P304
P356
10.1593/NEO.13376
P577
2013-08-01T00:00:00Z